Join +750K new investors every month who copy stock picks from billionaire's portfoliosSign Up Free

Alternative lenders gain ground in U.S. as investors support aggressive deals

Published 02/10/2017, 12:15 PM
Updated 02/10/2017, 12:20 PM
© Reuters.  Alternative lenders gain ground in U.S. as investors support aggressive deals
GS
-
HLF
-

By Jonathan Schwarzberg

NEW YORK (Reuters LPC) - Red-hot investor demand for U.S. leveraged loans is helping institutions not bound by federal lending guidelines to lead and sell aggressive deals that traditional arranging banks are unable to provide.

Deals that could have drawn regulators’ ire if arranged by traditional banks, including a US$1.375bn repricing for mixed martial arts franchise Ultimate Fighting Championship (UFC), which was originally criticized for accounting adjustments, and a highly leveraged US$1.6bn repricing for Tibco Software, sailed through the market when led by KKR and Jefferies, respectively.

Demand is strongly exceeding a limited supply of new deals in the US market as cash continues to pour into the asset class. Investors are doing their own credit work and often feel comfortable buying transactions that may have been criticized by regulators seeking to limit risk in the banking system.

“We are not subject to leverage lending guidelines at this point, and we’re not criticized like a bank would be. It lets us do our own credit work, which I think is a good thing. We don’t have to rely on the regulators to tell us if it’s a good or bad loan. I don’t think we have ever turned down a deal because we didn’t think it would pass,” said Lauren Basmadjian, portfolio manager at Octagon Credit, which invests in leveraged loans.

The Federal Reserve, the Federal Deposit Insurance Corp and the Office of the Comptroller of the Currency released updated leveraged lending guidance in 2013 to curtail aggressive lending. Some lenders, such as KKR and Jefferies, are not subject to the guidance and are stepping up their profile as loan arrangers.

The repricing of UFC’s US$1.375bn term loan gave KKR a chance to step up and lead a deal that was criticized by regulators last year due to aggressive Ebitda add-backs, which allow companies to use future estimates of growth to increase Ebitda which lowers adjusted leverage levels.

Goldman Sachs (NYSE:GS) led the original UFC deal in August 2016 and seven banks agreed to arrange the debt for the company’s buyout by Silver Lake Partners and KKR-backed talent agency WME-IMG.

KKR, which acted as an equity investor in the initial deal, took over as sole lead arranger on the repricing from the original banks as part of its efforts to boost its underwriting profile.

“When it comes to arranging debt financing, we focus on companies with attractive credit profiles that the institutional debt markets will support. Some situations are subject to limitations under the guidelines while many others are not,” Cade Thompson, head of US debt capital markets at KKR Capital Markets, said.

UFC’s repricing was well received by investors, which allowed the company to obtain substantial cost savings by cutting pricing by 75bp to 325bp over Libor only six months after the original deal was issued.

“KKR has been able to carve out a really nice niche for itself in some of these deals and been doing a good job picking and choosing spots where the traditional banks are pulling back,” said Michael Terwilliger, a global portfolio manager at investment firm Resource America.

Highly leveraged Tibco Software was also able to make significant savings as it switched to Jefferies, which is not subject to lending guidelines, to lead its US$1.6bn repricing. The original deal ran into difficulties over its higher leveraged levels in 2014 amid market volatility, and underwriters were forced to sell it at a discount of 95 cents on the dollar as investors pushed back against the high leverage.

Jefferies successfully completed the repricing in January and cut the spread by 100bp to 450bp over Libor from 550bp over Libor despite leverage of 7.5 times, which is significantly lower than the 11 times in 2014, according to Moody’s, but exceeds regulators’ hurdle of 6 times, which is one of the measures that regulators use to determine whether deals need more scrutiny. The loan was originally led jointly by JP Morgan, Jefferies and others.

The growing role of non-traditional lenders as arrangers of leveraged loans is helping to push average leverage ratios higher. Leverage has increased to 6.5 times in 2017 so far, which is the highest level since 2014, according to Thomson Reuters LPC data.

SOME RESTRAINT

Although investor demand shows no sign of slowing as strong loan inflows continue, loan buyers are still showing some discipline around deals with low pricing levels and are prepared to push for improved terms.

Nutritional supplement maker Herbalife (NYSE:HLF) had to increase pricing to 550bp over Libor from initial guidance of 375bp over Libor to place a loan that was then increased to US$1.3bn from US$1.175bn after investors flocked in at the higher pricing point. The company will use the loan to refinance its revolving credit facility and put cash on its balance sheet.

B1-rated construction products company ABC Supply Co was forced to postpone a repricing deal on February 7 after investors failed to support a 50bp pricing cut to only 225bp from 275bp on a US$1.875bn term loan, which pushed repricing limits, sources said.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.